Elutia (ELUT) Cash from Investing Activities (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Elutia | 45.79 Mn | 17.31 Mn | 1.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -100.04% |
| Dec 31, 2025 | 12,731.90% |
| Sep 30, 2025 | -452.63% |
| Jun 30, 2025 | 58.99% |
| Mar 31, 2025 | -195.74% |
| Dec 31, 2024 | 82.82% |
| Sep 30, 2024 | -400.55% |
| Jun 30, 2024 | 1,313.33% |
| Mar 31, 2024 | -100.10% |
| Dec 31, 2023 | 23,546.77% |
| Sep 30, 2023 | 27.06% |
| Jun 30, 2023 | 53.30% |
| Mar 31, 2023 | -35.82% |
| Dec 31, 2022 | -14.53% |
| Sep 30, 2022 | 54.12% |
| Jun 30, 2022 | -650.00% |
| Mar 31, 2022 | -36.00% |
| Dec 31, 2021 | 74.23% |
| Sep 30, 2021 | 16.38% |
| Jun 30, 2021 | 11.45% |
| Mar 31, 2021 | -13.91% |
| Dec 31, 2020 | 73.62% |
| Sep 30, 2020 | -1,514.81% |
| Jun 30, 2020 | 56.45% |
| Mar 31, 2020 | 60.00% |